Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Nitrate in Becker Muscular Dystrophy
NCT02434627Phase 1Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Jun 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sodium nitrate in Becker muscular dystrophy (BMD), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Change in maximal handgrip strength at 3 months. Started Jun 2015; status: completed.
02
Drugs
sodium nitrate
03
Conditions
Becker muscular dystrophy (BMD)
Beyond the preview
Go deeper on NCT02434627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434627.